| Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 S Chiba, M Baghdadi, H Akiba, H Yoshiyama, I Kinoshita, H Dosaka-Akita, ... Nature immunology 13 (9), 832-842, 2012 | 807 | 2012 |
| Chemotherapy-induced IL34 enhances immunosuppression by tumor-associated macrophages and mediates survival of chemoresistant lung cancer cells M Baghdadi, H Wada, S Nakanishi, H Abe, N Han, WE Putra, D Endo, ... Cancer research 76 (20), 6030-6042, 2016 | 171 | 2016 |
| Chemotherapy-derived inflammatory responses accelerate the formation of immunosuppressive myeloid cells in the tissue microenvironment of human pancreatic cancer S Takeuchi, M Baghdadi, T Tsuchikawa, H Wada, T Nakamura, H Abe, ... Cancer research 75 (13), 2629-2640, 2015 | 153 | 2015 |
| TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance M Baghdadi, A Yoneda, T Yamashina, H Nagao, Y Komohara, S Nagai, ... Immunity 39 (6), 1070-1081, 2013 | 123 | 2013 |
| Interleukin-34, a comprehensive review M Baghdadi, Y Umeyama, N Hama, T Kobayashi, N Han, H Wada, ... Journal of leukocyte biology 104 (5), 931-951, 2018 | 118 | 2018 |
| High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers M Baghdadi, H Endo, A Takano, K Ishikawa, Y Kameda, H Wada, ... Scientific reports 8 (1), 418, 2018 | 112 | 2018 |
| Interleukin 34, from pathogenesis to clinical applications M Baghdadi, H Endo, Y Tanaka, H Wada, K Seino Cytokine 99, 139-147, 2017 | 75 | 2017 |
| Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells T Yamashina, M Baghdadi, A Yoneda, I Kinoshita, S Suzu, ... Cancer research 74 (10), 2698-2709, 2014 | 66 | 2014 |
| Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas M Baghdadi, H Nagao, H Yoshiyama, H Akiba, H Yagita, H Dosaka-Akita, ... Cancer Immunology, Immunotherapy 62, 629-637, 2013 | 64 | 2013 |
| Regulation of cancer stem cell activities by tumor-associated macrophages M Jinushi, M Baghdadi, S Chiba, H Yoshiyama American journal of cancer research 2 (5), 529, 2012 | 64 | 2012 |
| Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells M Kanda, H Yamanaka, S Kojo, Y Usui, H Honda, Y Sotomaru, M Harada, ... Proceedings of the National Academy of Sciences 113 (24), E3394-E3402, 2016 | 53 | 2016 |
| Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity M Muto, M Baghdadi, R Maekawa, H Wada, K Seino Cancer immunology, immunotherapy 64, 941-949, 2015 | 43 | 2015 |
| The impact of the TIM gene family on tumor immunity and immunosuppression M Baghdadi, M Jinushi Cellular & molecular immunology 11 (1), 41-48, 2014 | 39 | 2014 |
| Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma N Han, M Baghdadi, K Ishikawa, H Endo, T Kobayashi, H Wada, ... Inflammation and Regeneration 38, 1-5, 2018 | 37 | 2018 |
| Efficient generation of thymic epithelium from induced pluripotent stem cells that prolongs allograft survival R Otsuka, H Wada, H Tsuji, A Sasaki, T Murata, M Itoh, M Baghdadi, ... Scientific reports 10 (1), 224, 2020 | 32 | 2020 |
| ATM-mediated DNA damage signals mediate immune escape through integrin-αvβ3–dependent mechanisms M Jinushi, S Chiba, M Baghdadi, I Kinoshita, H Dosaka-Akita, K Ito, ... Cancer research 72 (1), 56-65, 2012 | 31 | 2012 |
| A role for IL-34 in osteolytic disease of multiple myeloma M Baghdadi, K Ishikawa, S Nakanishi, T Murata, Y Umeyama, ... Blood advances 3 (4), 541-551, 2019 | 28 | 2019 |
| New immunosuppressive cell therapy to prolong survival of induced pluripotent stem cell–derived allografts H Sasaki, H Wada, M Baghdadi, H Tsuji, R Otsuka, K Morita, N Shinohara, ... Transplantation 99 (11), 2301-2310, 2015 | 27 | 2015 |
| Interleukin-34 expression in ovarian cancer: a possible correlation with disease progression H Endo, N Hama, M Baghdadi, K Ishikawa, R Otsuka, H Wada, H Asano, ... International immunology 32 (3), 175-186, 2020 | 26 | 2020 |
| Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphoma Y Komohara, O Noyori, Y Saito, H Takeya, M Baghdadi, F Kitagawa, ... Journal of clinical and experimental hematopathology 58 (4), 152-160, 2018 | 23 | 2018 |
